Recently the University of Arizona licensed one of its latest technologies, a formulation for a new sunscreen, to a local company. The value of this new technology is the ingredients are combined in such a way that it keeps it from seeping into the skin. And that presented a great licensing opportunity for a small company who spotted the IP.
New therapeutic drug treatments are rapidly entering the market. They’re designed to treat all sorts of diseases from headaches to diabetes. It’s a multi-billion dollar industry that’s highly competitive. The challenge is how do you stand out not only from the competition but also to the consumer.
Many times what goes in a product is more important than the product itself. And that presents a great licensing opportunity. That’s just what one cannabis company decided to do. Rather than use their technology to make and sell products, they use their R&D technology to help other product manufacturers deliver better and more consistent products.
When licensing a new technology, try before you buy is a good option to consider. One way of doing that is to test drive it using an evaluation license before committing to a full license. Evaluation licensees offer several key advantages: They’re a low-cost, non-exclusive short-term license that gives you […]
The value of your IP is derived from what it does. It’s based on the economic benefits your IP delivers – increasing revenues, reducing costs, creating new products and extending product or technology lifespans. The more of these economic benefits that your IP provides, the greater its value. Increase revenues […]